BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 84 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,403,000 | -2.2% | 55,463 | +5.0% | 0.04% | -7.5% |
Q3 2017 | $2,457,000 | -6.0% | 52,811 | 0.0% | 0.04% | -11.1% |
Q2 2017 | $2,615,000 | -12.7% | 52,811 | -3.4% | 0.04% | -15.1% |
Q1 2017 | $2,995,000 | -3.9% | 54,658 | -2.3% | 0.05% | -10.2% |
Q4 2016 | $3,117,000 | +21.3% | 55,958 | -0.5% | 0.06% | +13.5% |
Q3 2016 | $2,569,000 | +14.3% | 56,247 | 0.0% | 0.05% | +8.3% |
Q2 2016 | $2,247,000 | +14.7% | 56,247 | 0.0% | 0.05% | +11.6% |
Q1 2016 | $1,959,000 | -19.5% | 56,247 | -0.7% | 0.04% | -21.8% |
Q4 2015 | $2,434,000 | -0.7% | 56,647 | +0.6% | 0.06% | -5.2% |
Q3 2015 | $2,452,000 | -15.6% | 56,310 | 0.0% | 0.06% | -9.4% |
Q2 2015 | $2,906,000 | +31.8% | 56,310 | 0.0% | 0.06% | +33.3% |
Q1 2015 | $2,205,000 | -1.4% | 56,310 | -2.8% | 0.05% | -4.0% |
Q4 2014 | $2,237,000 | +11.1% | 57,926 | +1.6% | 0.05% | +4.2% |
Q3 2014 | $2,013,000 | +31.0% | 57,022 | 0.0% | 0.05% | +33.3% |
Q2 2014 | $1,537,000 | -1.9% | 57,022 | -5.7% | 0.04% | -5.3% |
Q1 2014 | $1,567,000 | +19.6% | 60,462 | 0.0% | 0.04% | +18.8% |
Q4 2013 | $1,310,000 | +12.9% | 60,462 | +1.5% | 0.03% | 0.0% |
Q3 2013 | $1,160,000 | +28.0% | 59,558 | +2.6% | 0.03% | +18.5% |
Q2 2013 | $906,000 | – | 58,059 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 211,370 | $9,833,000 | 5.80% |
JW Asset Management, LLC | 73,649 | $3,426,000 | 2.51% |
NORTHPOINTE CAPITAL LLC | 135,657 | $6,311,000 | 0.67% |
Elk Creek Partners, LLC | 170,102 | $7,913,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 156,167 | $7,265,000 | 0.32% |
Ativo Capital Management LLC | 22,592 | $1,051,000 | 0.28% |
Matarin Capital Management, LLC | 59,077 | $2,748,262,000 | 0.23% |
ISTHMUS PARTNERS, LLC | 16,753 | $779,000 | 0.22% |
CADENCE CAPITAL MANAGEMENT LLC | 29,586 | $1,376,000 | 0.09% |
ALGERT GLOBAL LLC | 7,834 | $364,000 | 0.08% |